1. A Perspective on Emerging Therapeutic Interventions for COVID-19
    Muhammad Torequl Islam et al, 2020, Front. Public Health CrossRef
  2. Physicians’ Perspectives on COVID-19: An International Survey
    Alina Dima et al, 2020, Healthcare CrossRef
  3. The Under-Reported Role of Toxic Substance Exposures in the COVID-19 Pandemic
    Ronald N. Kostoff et al, 2020, Food and Chemical Toxicology CrossRef
  4. Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention
    Aikaterini Nasi et al, 2020, Toxicology Reports CrossRef
  5. Probiotics: Versatile Bioactive Components in Promoting Human Health
    Javad Sharifi-Rad et al, 2020, Medicina CrossRef
  6. COVID-19 vaccines: ethical framework concerning human challenge studies
    Daniela Calina et al, 2020, DARU J Pharm Sci CrossRef
  7. Lactoferrin as potential preventative and adjunct treatment for COVID-19
    Raymond Chang et al, 2020, International Journal of Antimicrobial Agents CrossRef
  8. The Natural-Mineral-Based Novel Nanomaterial IFMC Increases Intravascular Nitric Oxide without Its Intake: Implications for COVID-19 and beyond
    Tomohiro Akiyama et al, 2020, Nanomaterials CrossRef
  9. Rheumatologists in the COVID-19 era: will there be a new role for the rheumatologist in the care of rheumatic patients?
    Jorge Morales-Torres et al, 2020, Clin Rheumatol CrossRef
  10. Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives
    Chandan Sarkar et al, 2020, Front. Pharmacol. CrossRef
  11. SARS-CoV-2 vaccine development: An overview and perspectives
    Yi Liu et al, 2020, ACS Pharmacol. Transl. Sci. CrossRef
  12. A brief outlook on the current emerging trends of COVID 19 vaccines
    Smitha Thammaiaha et al, 2020, J Oral Maxillofac Pathol CrossRef
  13. Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System
    Maria Lima et al, 2020, Curr Treat Options Neurol CrossRef
  14. The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
    Soheila Molaei et al, 2020, International Immunopharmacology CrossRef
  15. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19
    Aristides Tsatsakis et al, 2020, Food and Chemical Toxicology CrossRef
  16. Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development
    Daniela Calina et al, 2020, Immunol Res CrossRef
  17. SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening
    Cristina Adriana Dehelean et al, 2020, JCM CrossRef
  18. Pharmacological Activities of Psoralidin: A Comprehensive Review of the Molecular Mechanisms of Action
    Javad Sharifi-Rad et al, 2020, Front. Pharmacol. CrossRef
  19. Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety
    Ronald N. Kostoff et al, 2020, Toxicology Reports CrossRef
  20. Structure of the SARS-CoV-2 Nsp1/5′-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence
    Naveen Vankadari et al, 2020, J. Phys. Chem. Lett. CrossRef
  21. COVID-19 in health-care workers: lessons from SARS and MERS epidemics and perspectives for chemoprophylaxis and vaccines.
    Rémi Labetoulle et al, 2020, Expert Review of Vaccines CrossRef
  22. The dangers of performative scientism as the alternative to anti-scientific policymaking: A critical, preliminary assessment of South Africa’s Covid-19 response and its consequences
    Seán M. Muller, 2020, World Development CrossRef
  23. An Italian Guidance Model for the Management of Suspected or Confirmed COVID-19 Patients in the Primary Care Setting
    Noemi Lopes et al, 2020, Front. Public Health CrossRef
  24. One Year Update on the COVID-19 Pandemic: Where Are We Now?
    Sanjay Kumar Mishra et al, 2020, Acta Tropica CrossRef
  25. Why METH users are at high risk of fatality due to COVID-19 infection?
    Md Kamal Hossain et al, 2020, Expert Review of Vaccines CrossRef
  26. COVID-19 in the elderly people and advances in vaccination approaches
    Kuldeep Dhama et al, 2020, Human Vaccines & Immunotherapeutics CrossRef
  27. Nicotinic Cholinergic System and COVID-19: In Silico Evaluation of Nicotinic Acetylcholine Receptor Agonists as Potential Therapeutic Interventions
    Nikolaos Alexandris et al, 2020, Toxicology Reports CrossRef
  28. THROMBOSIS AND HAEMOSTASIS CHALLENGES IN COVID-19 – THERAPEUTIC PERSPECTIVES OF HEPARIN AND TISSUE-TYPE PLASMINOGEN ACTIVATOR AND POTENTIAL TOXICOLOGICAL REACTIONS-A MINI REVIEW
    Laura Mazilu et al, 2021, Food and Chemical Toxicology CrossRef
  29. Dietary supplements, vitamins and minerals as potential interventions against viruses: Perspectives for COVID-19.
    Muhammad Torequl Islam et al, 2021, Int J Vitam Nutr Res CrossRef
  30. Immune response scenario and vaccine development for SARS-CoV-2 infection
    Mai H.S. Mohammad, 2021, International Immunopharmacology CrossRef
  31. Maternal Vaccines - Safety in pregnancy
    Mala Arora et al, 2021, Best Practice & Research Clinical Obstetrics & Gynaecology CrossRef
  32. An overview of vaccine development for COVID-19
    Seyed H Shahcheraghi et al, 2021, Therapeutic Delivery CrossRef
  33. The find of COVID-19 vaccine: Challenges and opportunities
    Marwan ElBagoury et al, 2021, Journal of Infection and Public Health CrossRef
  34. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates
    Malik Sallam, 2021, Vaccines CrossRef
  35. COVID‐19 into Chemical Science Perspective: Chemical Preventive Measures and Drug Development
    Bimalendu Adhikari et al, 2021, ChemistrySelect CrossRef
  36. COVID-19 pandemic and alcohol consumption: impacts and interconnections
    Daniela Calina et al, 2021, Toxicology Reports CrossRef
  37. Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review)
    George Nitulescu et al, 2020, Int J Mol Med CrossRef
  38. Back to basics in COVID‐19: Antigens and antibodies—Completing the puzzle
    Monica Neagu et al, 2021, J Cell Mol Med CrossRef
  39. Keeping governments accountable: the COVID-19 Assessment Scorecard (COVID-SCORE)
    Jeffrey V. Lazarus et al, 2020, Nat Med CrossRef
  40. [Editorial] COVID‑19: Post‑lockdown guidelines
    Ronald Kostoff et al, 2020, Int J Mol Med CrossRef
  41. A dissection of SARS‑CoV2 with clinical implications (Review)
    Felician Stancioiu et al, 2020, Int J Mol Med CrossRef
  42. COVID-19 Vaccine Challenges: What have we learned so far and what remains to be done?
    Rebecca Forman et al, 2021, Health Policy CrossRef
  43. Research, Development and Application of COVID-19 Vaccines: Progress, Challenges, and Prospects
    Gong Feng et al, 2021 CrossRef
  44. SARS-CoV-2 infection incidence during the first and second COVID-19 waves in Italy.
    Marco Vinceti, 0 CrossRef
  45. Safety of COVID-19 vaccines administered in the EU: Should we be concerned?
    Antonio F. Hernández et al, 2021, Toxicology Reports CrossRef
  46. Flavonoids are promising safe therapy against COVID-19
    Moza Mohamed Alzaabi et al, 2021, Phytochem Rev CrossRef
  47. Identifying US County-level characteristics associated with high COVID-19 burden
    Daniel Li et al, 2021, BMC Public Health CrossRef
  48. COVID‐19 vaccines and nanomedicine
    Robert S. Shapiro, 2021, Int J Dermatol CrossRef
  49. Protective Action of L. salivarius SGL03 and Lactoferrin against COVID-19 Infections in Human Nasopharynx
    Marzena Kucia et al, 2021, Materials CrossRef
  50. Epitope-Specific Response of Human Milk Immunoglobulins in COVID-19 Recovered Women
    Tatyana V. Bobik et al, 2021, Pathogens CrossRef
  51. SARS-CoV-2: Origin, Evolution, and Targeting Inhibition
    Shuo Ning et al, 2021, Front. Cell. Infect. Microbiol. CrossRef
  52. Challenges of COVID-19 and Tuberculosis - Urgent Need to Tackle the Dual Burden
    Karma Gurmey Dolma et al, 2021, jemds CrossRef
  53. Next-Generation Bioinformatics Approaches and Resources for Coronavirus Vaccine Discovery and Development—A Perspective Review
    Rahul Chatterjee et al, 2021, Vaccines CrossRef
  54. An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity
    Anne-Catherine Fluckiger et al, 2021, Vaccine CrossRef
  55. Silencing of long non-coding RNA KCNQ1OT1 alleviates LPS-induced lung injury by regulating the miR-370-3p/FOXM1 axis in childhood pneumonia
    Ping Wang et al, 2021, BMC Pulm Med CrossRef
  56. Disproportionate coronavirus disease 2019 (COVID-19) vaccine distribution—A great threat to low- and middle-income countries
    Prashant Upadhyay et al, 2021, Infect. Control Hosp. Epidemiol. CrossRef
  57. A contemporary insight into SARS-CoV-2 pathophysiology, retrieved threat of mutants and prospect of vaccine development
    Rasmita DASH et al, 2021, Minerva Biotechnol Biomol Res CrossRef
  58. A comprehensive insight on the COVID-19 vaccine candidates
    Anu Sharma et al, 2021, J Family Med Prim Care CrossRef
  59. Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection
    Lei Li et al, 2021, Vaccine CrossRef
  60. University students’ perspectives, planned uptake, and hesitancy regarding the COVID-19 vaccine: A multi-methods study
    Madeleine Mant et al, 2021, PLoS ONE CrossRef
  61. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review
    Maryam Sharifian-Dorche et al, 2021, Journal of the Neurological Sciences CrossRef
  62. Perspectives of dermatology specialists and residents on COVID‐19 vaccines: A questionnaire‐based survey
    Efsun Tanacan et al, 2021, Int J Clin Pract CrossRef
  63. null
    Ronald N. Kostoff et al, 2021 CrossRef
  64. null
    Taxiarchis Konstantinos Nikolouzakis et al, 2021 CrossRef
  65. An in silico scientific basis for LL-37 as a therapeutic for Covid-19.
    Kiran Bharat Lokhande et al, 2022, Proteins CrossRef
  66. Reporting at Least One Adverse Effect Post-COVID-19 Vaccination From Primary Health Care in Muscat
    Thamra S Al Ghafri et al, 2021 CrossRef
  67. Guillain‑Barré syndrome associated with Covid‑19: A close relationship or just a coincidence? (Review)
    Adina Stoian et al, 2021, Exp Ther Med CrossRef
  68. Professional ethics, VBAC and COVID‑19 pandemic: A challenge to be resolved (Review)
    Alexandru Carauleanu et al, 2021, Exp Ther Med CrossRef
  69. Immune thrombocytopenia, severe hematological consequence in a patient with COVID‑19: A case report
    Oana-Viola Badulescu et al, 2021, Exp Ther Med CrossRef
  70. Challenges and Progress in Vaccine Development for COVID-19 Coronavirus (SARS-CoV-2): A Review
    Keshav S. Moharir et al, 2021, TOCOVIDJ CrossRef
  71. Biopharmaceutics 4.0, Advanced Pre-Clinical Development of mRNA-Encoded Monoclonal Antibodies to Immunosuppressed Murine Models
    Andreas Ouranidis et al, 2021, Vaccines CrossRef
  72. SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
    Hadis Fathizadeh et al, 2021, International Journal of Biological Macromolecules CrossRef
  73. Vaccine Design and Delivery Approaches for COVID-19
    Kiana Shahzamani et al, 2021, International Immunopharmacology CrossRef
  74. Bioactive Compounds as Potential Agents for Sexually Transmitted Diseases Management: A Review to Explore Molecular Mechanisms of Action
    Javad Sharifi-Rad et al, 2021, Front. Pharmacol. CrossRef
  75. Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2
    Siya Kamat et al, 2021, Journal of Controlled Release CrossRef
  76. COVID-19 vaccine hesitancy and willingness to pay: Emergent factors from a cross-sectional study in Nigeria
    Obi Peter Adigwe, 2021, Vaccine: X CrossRef
  77. High‑dose intravenous immunoglobulins as a therapeutic option in critical illness polyneuropathy accompanying SARS‑CoV‑2 infection: A case‑based review of the literature (Review)
    Adina Stoian et al, 2021, Exp Ther Med CrossRef
  78. Why are We Vaccinating Children against COVID-19?
    Ronald N. Kostoff et al, 2021, Toxicology Reports CrossRef
  79. COVID-19: A HEALTH PERSPECTIVE
    SHEENA WONG et al, 2021, J. Bus. Econ. A. CrossRef
  80. Discovery of potential SARS-CoV 3CL protease inhibitors from approved antiviral drugs using: virtual screening, molecular docking, pharmacophore mapping evaluation and dynamics simulation
    Ismail Daoud et al, 2021, Journal of Biomolecular Structure and Dynamics CrossRef
  81. Understanding the Last Mile Transportation Concept Impacting Underserved Global Communities to Save Lives During COVID-19 Pandemic
    Erick C. Jones et al, 2021, Front. Future Transp. CrossRef
  82. COVID-19 and Cancer Therapy: Interrelationships and Management of Cancer Cases in the Era of COVID-19
    Simon N. Mbugua et al, 2021, Journal of Chemistry CrossRef
  83. Effect of gentle exercises on injection site reaction after Covid-19 vaccination. A case report
    Varun Kalia, 2021, Journal of Bodywork and Movement Therapies CrossRef
  84. Tracking the progress in COVID-19 and vaccine safety research – a comprehensive bibliometric analysis of publications indexed in Scopus database
    Tosin Yinka Akintunde et al, 2021, Human Vaccines & Immunotherapeutics CrossRef
  85. Attitudes of Healthcare Professionals and General Population Toward Vaccines and the Intention to Be Vaccinated Against COVID-19 in Spain
    Isabel Iguacel et al, 2021, Front. Public Health CrossRef
  86. Impact of COVID‑19 prevention measures on Clostridioides difficile infections in a regional acute care hospital
    Simona Sipos et al, 2021, Exp Ther Med CrossRef
  87. Prediction of in‑hospital recurrence and false‑negative results in patients with COVID‑19 by red blood cell values on admission
    Xue Jiang et al, 2021, Exp Ther Med CrossRef
  88. Extracorporeal membrane oxygenation in the management of critically ill patients with coronavirus disease 2019: A narrative review
    Alexandru Pleșoianu et al, 2021, Exp Ther Med CrossRef
  89. Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena
    Vivek P. Chavda et al, 2021, Biologics CrossRef
  90. Lung ultrasound in predicting COVID‐19 clinical outcomes: A prospective observational study
    Mojtaba Chardoli et al, 2021, Journal of the American College of Emergency Physicians Open CrossRef
  91. Policy Stringency, Handwashing and COVID-19 cases: Evidence from Global dataset
    Janet Dzator et al, 2021, Health Policy and Technology CrossRef
  92. Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain
    Isabel Iguacel et al, 2021, Vaccines CrossRef
  93. Haematological malignancies implications during the times of the COVID‑19 pandemic (Review)
    Eleni Papakonstantinou et al, 2021, Oncol Lett CrossRef
  94. Demographic, anthropometric, and metabolic characteristics of obstructive sleep apnea patients from Romania before the COVID‑19 pandemic
    Adriana Neagos et al, 2021, Exp Ther Med CrossRef
  95. In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation
    Rajib Hossain et al, 2021, Chin. J. Integr. Med. CrossRef
  96. Comparative analysis of existing platforms for the development of vaccines against dangerous and extremely dangerous viral infections with pandemic potential
    G. G. Onishchenko et al, 2021, Biopreparaty. Profilaktika, diagnostika, lechenie CrossRef
  97. The race for a COVID-19 vaccine: where are we up to?
    Md Kamal Hossain et al, 2021, Expert Review of Vaccines CrossRef
  98. Suicidality and COVID-19: Suicidal ideation, suicidal behaviors and completed suicides amidst the COVID-19 pandemic (Review).
    Vasiliki Efstathiou et al, 2022, Exp Ther Med CrossRef
  99. Acute kidney injury in moderate and severe COVID‑19 patients: Report of two university hospitals
    Daniela Radulescu et al, 2021, Exp Ther Med CrossRef
  100. Diagnostic challenges, management, and outcome of infants born to mothers with COVID 19 during the first wave of the pandemic
    Gabriela Zaharie et al, 2021, Exp Ther Med CrossRef
  101. Therapeutic plasma exchange followed by convalescent plasma transfusion in severe and critically ill COVID‑19 patients: A single centre non‑randomized controlled trial
    Alexandru Novacescu et al, 2021, Exp Ther Med CrossRef
  102. DNA vaccines against COVID-19: Perspectives and challenges
    Marcelle Moura Silveira et al, 2021, Life Sciences CrossRef
  103. The role of nursing professionals and challenges encountered in the effective containment of the ongoing COVID-19 pandemic
    SaurabhRamBihariLal Shrivastava et al, 2021, Acta Med Int CrossRef
  104. Naturally occurring anthraquinones as potential inhibitors of SARS-CoV-2 main protease: an integrated computational study
    Sourav Das et al, 2022, Biologia CrossRef
  105. Clinical and statistical assessment of the reproductive health of fertilized women in the Tyumen region and the risks of miscarriage in Western Siberia
    E. A. Mateykovich et al, 2022, Medicinskij sovet CrossRef
  106. Serum amyloid A, ferritin and carcinoembryonic antigen as biomarkers of severity in patients with COVID‑19
    Dina Abdelhakam et al, 2021, Biomed Rep CrossRef
  107. Forecasting the COVID-19 vaccine uptake rate: an infodemiological study in the US
    Xingzuo Zhou et al, 2022, Human Vaccines & Immunotherapeutics CrossRef
  108. Global landscape of COVID-19 vaccination progress: insight from an exploratory data analysis
    Samrat Kumar Dey et al, 2022, Human Vaccines & Immunotherapeutics CrossRef
  109. An Exploration of COVID-19 Impact and Vaccine Hesitancy in Parents of Pediatric Hematopoietic Stem Cell Transplant (HCT) Recipients
    Micah Skeens et al, 2022, Bone Marrow Transplant CrossRef
  110. Covid-19 vaccine acceptance and associated factors among pregnant women in Pennsylvania 2020
    Kristin K. Sznajder et al, 2022, Preventive Medicine Reports CrossRef
  111. Bacterial endocarditis masked by COVID‑19: A case report
    Mircea Bajdechi et al, 2021, Exp Ther Med CrossRef
  112. Treatment of patients with Covid‑19 with a high dose of ulinastatin
    Hai Huang et al, 2021, Exp Ther Med CrossRef
  113. Assessment of attitude and hesitancy toward vaccine against COVID-19 in a Pakistani population: A mix methods survey
    Z.A. Khan et al, 2021, Vacunas CrossRef
  114. A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson
    Rikin Patel et al, 2022, Human Vaccines & Immunotherapeutics CrossRef
  115. COVID-19 Vaccine Hesitancy among Health Workers in Surgical Departments in Port Harcourt, Nigeria
    Promise N.W. et al, 2022, African Journal of Biology and Medical Research CrossRef
  116. COVID-19 vaccines: a look at the ethics of the clinical research involving children
    Laura Cabiedes-Miragaya et al, 2022, J Med Ethics CrossRef
  117. Bi-objective Optimization for a Multi-period COVID-19 Vaccination Planning Problem
    Lianhua Tang et al, 2022, Omega CrossRef
  118. An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission
    Kairat Tabynov et al, 2022, npj Vaccines CrossRef
  119. A Data-Driven Robust Optimization Model by Cutting Hyperplanes on Vaccine Access Uncertainty in COVID-19 Vaccine Supply Chain
    Hani Gilani et al, 2022, Omega CrossRef
  120. Analyzing the Morality of Owning and Suspending Patent Rights for COVID-19 Vaccines in the Light of Catholic Social Teaching
    Vivencio O. Ballano, 2022, Linacre Q CrossRef
  121. COVID-19 Vaccination Among the Arab Bedouin Population: Lessons Learned From a Minority Population
    Naim Abu-Freha et al, 2022, Int J Public Health CrossRef
  122. Perceived Vaccine Efficacy, Willingness to Pay for COVID-19 Vaccine and Associated Determinants among Foreign Migrants in China
    Tosin Yinka Akintunde et al, 2022, ELECTRON J GEN MED CrossRef
  123. COVID-19 vaccine candidates: A review
    Martyna Biała et al, 2021 CrossRef
  124. SARS‑CoV‑2 infection and children: Insights from the 6th Workshop on Paediatric Virology (Review)
    Ioannis Mammas et al, 2022, World Acad Sci J CrossRef
  125. Clinical characteristics of patients with acute ischemic stroke previously vaccinated against COVID-19
    Marija Stamenković et al, 2022, Journal of Stroke and Cerebrovascular Diseases CrossRef
  126. Participation of Religious Leaders in Helping the Success of the Government's COVID-19 Vaccination Program
    Simon Simon et al, 2021, EJTI CrossRef
  127. Analyzing the factors that will impact the supply chain of the COVID-19 vaccine: A structural equation modeling approach
    Subhodeep Mukherjee et al, 2022, Journal of Statistics and Management Systems CrossRef
  128. Multiple evanescent white dot syndrome following BNT162b2 mRNA COVID-19 vaccination
    Eriko Yasuda et al, 2022, American Journal of Ophthalmology Case Reports CrossRef
  129. Determinants of Covid-19 Vaccine Acceptance among Students: A Web-Based Global Survey
    S. Fatima Irfan et al, 2022, EJMED CrossRef
  130. Pregnancy outcomes and thyroid dysfunction: preterm birth risk assessment
    E. A. Mateykovich et al, 2022, Medicinskij sovet CrossRef
  131. Rupture of Vertebral Artery Dissecting Aneurysm after mRNA Anti-COVID-19 Vaccination: A Report of Two Cases
    Kohei CHIDA et al, 2022 CrossRef
  132. null
    Mahyar Kolivand et al, 2022 CrossRef
  133. COVID-19 management landscape- A need for an affordable to manufacture safe and efficacious bio-therapeutic and prophylactic for developing countries
    Vyankatesh Pidiyar et al, 2022, Vaccine CrossRef
  134. GC-MS profiling of Bauhinia variegata major phytoconstituents with computational identification of potential lead inhibitors of SARS-CoV-2 Mpro
    Pallavi More-Adate et al, 2022, Computers in Biology and Medicine CrossRef
  135. null
    Mouraya Hussein et al, 2022 CrossRef
  136. Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms
    Ameneh Jafari et al, 2022, Mol Biol Rep CrossRef
  137. Exploring the Chinese Public’s Perception of Omicron Variants on Social Media: LDA-Based Topic Modeling and Sentiment Analysis
    Han Wang et al, 2022, IJERPH CrossRef
  138. A RECENT REVIEW ON: CORONAVIRUS DISEASE 2019
    MANDEEP SINGH et al, 2022, Asian J Pharm Clin Res CrossRef
  139. COVID-19 vaccine uptake and associated factors among pregnant women attending antenatal care in Debre Tabor public health institutions: A cross-sectional study
    Endeshaw Chekol Abebe et al, 2022, Front. Public Health CrossRef
  140. New onset of acute uveitis following COVID-19 vaccination
    Ha Eun Sim et al, 2022, Graefes Arch Clin Exp Ophthalmol CrossRef
  141. Antibodies in the breastmilk of COVID-19 recovered women
    Paulina Szczygioł et al, 2022, BMC Pregnancy Childbirth CrossRef
  142. COVID-19 and vaccination: myths vs science
    Vivek P. Chavda et al, 2022, Expert Review of Vaccines CrossRef
  143. Analysis of Double-Chain Deoxyribonucleic Acid Dynamical System in Pandemic Confrontation
    Shao-Wen Yao et al, 2022, Results in Physics CrossRef
  144. The impact factors of social media users' forwarding behavior of COVID-19 vaccine topic: Based on empirical analysis of Chinese Weibo users
    Kun Sun et al, 2022, Front. Public Health CrossRef
  145. COVID-19 Vaccinating Russian Medical Students—Challenges and Solutions: A Cross-Sectional Study
    Olesya V. Kytko et al, 2022, IJERPH CrossRef
  146. Assessment of attitude and hesitancy toward vaccine against COVID-19 in a Pakistani population: A mix methods survey
    Z.A. Khan et al, 2022, Vacunas (English Edition) CrossRef
  147. Factors Associated with Vaccination Intention against the COVID-19 Pandemic: A Global Population-Based Study
    Junjie Huang et al, 2022, Vaccines CrossRef
  148. Towards the development of an epitope-focused vaccine for SARS-CoV-2
    Jacquelynne Cervantes-Torres et al, 2022, Vaccine CrossRef
  149. Predictors of COVID-19 Vaccine Acceptability among Patients Living with HIV in Northern Nigeria: A Mixed Methods Study
    Zubairu Iliyasu et al, 2022, CHR CrossRef
  150. Lateral Flow Immunoassay Reader Technologies for Quantitative Point-of-Care Testing
    Jongwon Park, 2022, Sensors CrossRef
  151. null
    Oxford York et al, 2022 CrossRef
  152. Perceived COVID-19 vaccine attributes associated with early adoption among adults in rural Indiana
    Kristina Hunter-Mullis et al, 2022 CrossRef
  153. An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity
    Nikita N. Kostin et al, 2022, Acta Naturae CrossRef
  154. null
    Vivencio O. Ballano, 2022 CrossRef
  155. Hesitation about coronavirus vaccines in healthcare professionals and general population in Spain
    Francesc Saigí-Rubió et al, 2022, PLoS ONE CrossRef